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Abstract  
Potassium levels in the plasma, [K+]o, are regulated precisely under physiological 
conditions. However, increases (from approx. 4.5 to 8.0 mM) can occur as a 
consequence of e.g. endurance exercise, ischemic insult or kidney failure. This 
hyperkalemic modulation of ventricular electrophysiology has been studied extensively. 
Hypokalemia is also common. It can occur in response to diuretic therapy, following 
renal dialysis, or during recovery from endurance exercise.  In the human ventricle, 
clinical hypokalemia (e.g. [K+]o levels of approx. 3.0 mM) can cause marked changes in 
both the resting potential and the action potential waveform, and these may promote 
arrhythmias. Here, we provide essential background information concerning the main 
K+-sensitive ion channel mechanisms that act in concert to produce prominent short-
term ventricular electrophysiological changes, and illustrate these by implementing 
recent mathematical models of the human ventricular action potential.  
Even small changes (~1mM) in [K+]o result in significant alterations in two 
different K+ currents, IK1 and HERG. These changes can markedly alter in resting 
membrane potential and/or action potential waveform in human ventricle. Specifically, a 
reduction in net outward transmembrane K+ currents (repolarization reserve) and an 
increased substrate input resistance contribute to electrophysiological instability during 
the plateau of the action potential and may promote pro-arrhythmic early after-
depolarizations (EADs). Translational settings where these insights apply include: 
optimal diuretic therapy, and the interpretation of data from Phase II and III trials for 






Rapid and effective regulation of plasma K+ levels, [K+]o, within a narrow range 
(3.5 - 5 mM) is a fundamental physiological principle in Cardiovascular Physiology.1  In 
most mammalian tissues the electrochemical gradient for K+ sets the resting potential.  
As a consequence, changes in [K+]o modulate essential parameters such as excitability 
and action potential duration (APD), as well as intracellular Ca2+, [Ca2+]i, and (thus) both 
excitation-contraction and excitation-secretion coupling.  The effects of deviations from 
normal [K+]o levels have been studied in detail in both physiological
2,3 and 
pathophysiological settings.4,5 As examples, in the heart the relatively short term 
increase in [K+]o that results from either maintained periods of high rates,
3 or a localized 
ischemic insult,4 have been well characterized. 
 Importantly, however, [K+]o can also decrease significantly for extended periods 
of time. This hypokalemia occurs in settings such as recovery from endurance exercise, 
or in the immediate post-dialysis time period in patients being treated for renal failure. 
Low [K+]o has also been reported in a number of increasingly common clinical settings 
when patients receive diuretic therapy as part of heart failure or hypertension 
treatments.6,7 Hypokalemia can occur even when this essential intervention is 
accompanied by K+ replacement, (so-called ‘Slow K+’ case management).  It often 
results in muscle cramping and can also produce supraventricular rhythm 
disturbances.8 In addition, [K+]o regulation in the rapidly growing healthy aging 
population is an increasing clinical challenge partly because very commonly used 
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therapeutic agents can alter [K+]o levels
8, and this sometimes changes cardiac 
electrophysiology in a patient-specific fashion.9 
The main purpose of this illustrated review is to further explore the direct 
electrophysiological consequences of somewhat reduced, but still physiological [K+]o 
levels of in the human ventricle.  At the outset, it is necessary to determine what is 
meant by ‘low physiological levels’ of [K+]o.  Recent reviews establish that normal 
plasma K+ activities fall in the range 3.9 - 4.2 mM.  [K+]o levels below approximately 3.5 
mM are defined as hypokalemic; and [K+]o levels in excess of 6.0 mM are considered to 
be hyperkalemic10,11  
Most of the physiological principles and molecular mechanisms by which [K+]o 
can alter the electrophysiological activity in the mammalian heart (including the human) 
are quite well known.12,13 However, some of these are not applied optimally in clinical 
settings or drug safety initiatives. The main K+ selective ion channel that senses and 
reacts strongly to small changes in [K+]o is the background inwardly rectifying K
+ current, 
IK1.
12-15 This highly nonlinear current changes in an unexpected (or anomalous) way in 
response to changes in [K+]o.
16,17  Specifically, when [K+]o is decreased (although the 
driving force for K+ increases at the level of the resting potential), the outward current 
flow that is essential for maintaining the resting potential decreases. The immediate 
consequences are: (i) a small hyperpolarization, (ii) an altered AP waveform,12, 14 (iii) a 
marked change in the input resistance at the resting potential,17 and (iv) a change in the 
impedance profile (input resistance) during the plateau of the AP18,19 This increase in 
impedance at the plateau of the AP alters (enhances) intercellular coupling in the atria, 
ventricles, and Purkinje conduction tissue. Previously, many of these principles were 
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incorporated into a mathematical model of the guinea pig ventricular action potential 
(Luo and Rudy,1991)20 and their consequences on the resting potential, action potential 
waveform and excitability were explored in detail.  
A second mechanism by which the intrinsic electrophysiological properties of the 
mammalian myocardium (mainly the ventricles) are changed in response to low [K+]o is 
via its influences or the time- and voltage-sensitive K+ current HERG.21,22 Even small 
alterations in [K+]o can be detected by these ‘delayed rectifier K
+ channels’. Once again, 
although decreased [K+]o increases electrochemical driving force for K
+, HERG 
channels generate a smaller outward current at the level of the plateau in low [K+]o
23. 
The mechanism for this important but complex change has been identified; small 
changes in [K+]o can alter the rapid, voltage-dependent inactivation of HERG 
channels.24-27  
Most previous accounts of low [K+]o effects have assumed that the myocardium 
consists of homogenous populations of myocytes and IK1 expression levels.  However, it 
is now known that IK1 is expressed in both fibroblasts and myofibroblasts.
28 These cells 
make connexin-based contacts with other fibroblasts and perhaps also with myocytes.28 
Thus, electrotonic effects of low [K+]o on action potential duration (APD) and excitability 
in both atria and ventricles, perhaps sensed/transduced by fibroblasts, are expected to 
contribute to the well-known pro-arrhythmic tendency of low [K+]o. 
In this review, we illustrate and document these low [K+]o induced 
electrophysiological changes by utilizing mathematical modeling. These simulations 
reveal an integrated pattern of results that can explain the unique ability of inwardly 
rectifying K+ channels (IK1 and HERG) to detect even very small [K
+]O  decreases and 
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rapidly change their properties (inactivation characteristics, and ion transfer 
relationships or current-voltage (I-V) curves, respectively). The net outward current in 
the physiological range of potentials is reduced in low [K+]o, and this small but 
functionally important decrease can alter both the resting potential and the 
repolarization waveform of the AP.20,21 We emphasize these changes as an essential 
common (but perhaps not well appreciated) mechanism for short-term 
electrophysiological responses to hypokalemia. We conclude by drawing attention to the 
possibility that relatively frequent observations that may appear to be proarrhythmic 
drug or drug candidate actions, can be partly a result of off-target efforts of alterations in 
[K+]O in atrial and ventricular substrates. 
30-33 
 
Even Small Changes in [K+]o  have Significant Effects  
Changes in [K+]o as small as +/- 1.5 mM from the physiological level (approx.. 4.2 
mM) can significantly alter the electrophysiological properties of human atria and 
ventricles. These effects are illustrated in Figure 1 in terms of the time-independent or 
background current (IK1); the two main time-and voltage-dependent or delayed rectifier 
currents, HERG or IKr and IKS; and the electrogenic current produced by the Na
+/K+ 
pump in human ventricular myocytes. The four superimposed AP’s in Panel A of Fig. 1 
were obtained using our modified version of the classical ORd model of the human 
ventricular action potential developed by the Rudy Group.33 This is described in detail in 
the Supplement Section. 
Perhaps the most prominent changes in the K+ currents that underlie the resting 
potential and action potential are those due to IK1. This highly nonlinear background K
+ 
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current changes almost instantly following changes in [K+]o in the +/- 2mM range. Thus, 
a decrease in [K+]o within the physiological range (e.g. 4.2 to 3.0 mM), results in an 
anomalous decrease in some functionally important K+ currents (IK1 and HERG, Figs. 1 
and S-1 and S-2) in human ventricle.  In a variety of cells and tissue subtypes, 
decreasing [K+]o also results in a marked change in the range of membrane voltage over 
which these K+-selective channels are active. This so-called ‘cross-over effect’ of the ion 
transfer or current-voltage relationship is a hallmark feature of the strongly inwardly 
rectifying K+ currents that are expressed in heart,12,15, 20 in skeletal muscle16 and also in 
smooth muscle myocytes from resistance vessels,35,36 in both endothelial cells, and 
vascular pericytes.37 
These changes are apparent both under control conditions (either 5.4 or 4.2 
mM), and in response to the physiological increases in [K+]o (8 mM), or decreases in 
plasma [K+]o that have been identified in clinical settings and in individuals that are 
recovering from bouts of endurance exercise.2,3  
 
[Fig. 1 near here] 
 
In principle, a comprehensive understanding of the effects of alterations in 
plasma [K+]o on the resting potential and AP waveform also requires consideration of 
another time- and voltage-dependent delayed rectifier K+ current that is expressed in 
human ventricle. This current, denoted IKs, is distinct from the HERG K
+ current that is 
illustrated in Fig. 1C.38,39 Differences include: its activation kinetics are slower, its level 
of expression is much lower, and it shows conventional (as opposed to anomalous) 
 9 
dependence upon alterations in the electrochemical gradient for K+.39 That is, in this 
case, when the electrochemical driving force for K+ increases, (e.g. as a consequence 
of decrease in [K+]o from normal (5.4 or 4.2 mM) to approximately 3 mM), IKs increases 
with little or no change in time course or voltage dependence. The four superimposed 
traces in Panel D of Fig. 1 illustrate the changes in IKs during the APs shown in Panel A. 
Note, however, that this current in human ventricle (as opposed to its size in guinea pig 
ventricle20) is only approximately 10% the size of the outward peak current due to IK1 (as 
shown in Panel B). Nevertheless, at increased heart rates, and/or in the setting of 
enhanced sympathetic tone,40 IKs is known to have an important role in the final 
repolarization phase of the human ventricular AP.  
The four superimposed traces in Fig. 1E show the changes in electrogenic 
current due to the Na+/K+ pump during the APs illustrated in Fig. 1A.41 It is apparent that 
during the AP, this current change at any of the selected [K+]o values is very small, only 
perhaps 2% of that due to IK1. Nevertheless, a detectable outward current change is 
generated during the AP at each selected [K+]o level. This net outward current plays an 
essential role in overall K+ homeostasis of the myocyte and may also alter the 
repolarization waveform in human ventricle. Note, however, that the changes in this 
electrogenic or pump-mediated current are due to the alterations in the AP waveform 
produced by [K+]o. These depend on the intrinsic voltage-dependence of this enzyme, 
and the known dependence of its turnover rate on [K+]o.  However, since the affinity or 
Kd for the external binding site for K
+ on this Na+/K+ pump is approximately 2.0-2.5 
mM,42 the physiological changes in [K+]o, which are the focus of this paper, would not be 
considered to be primary or strong modulators of this small electrogenic current under 
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relatively short term changes in APD that occur in response to alterations in [K+]o. In 
contrast, during maintained periods of enhanced heart rate or extramural stimulation the 
contribution of this electrogenic Na+/K+ pump current may increase. 43,44 
The results in Figs. 1-2 (in context of Figs S-1 and S-2) provide most of the 
required information that is needed to integrate and then illustrate the 
electrophysiological consequences of altered [K+]o on the AP of baseline or healthy 
myocytes human ventricle. Both basic science and clinical papers utilize the concept:  
repolarization reserve in human ventricle to capture and discuss key aspects of action 
potential repolarization mechanisms and dynamics.45,46 Repolarization reserve is 
equivalent to the net outward current during a membrane or non conducted action 
potential.47  It is of interest to follow the changes in this parameter (i) during initiation of 
repolarization from the plateau, (ii) throughout final repolarization and (iii) also in the 
inter-stimulus interval, that is during diastole. The four superimposed I-V curves in Fig. 3 
illustrate the net current in the selected [K+]o levels that are the focus of this illustrated 
review with reference to the four corresponding AP waveforms in Fig. 1A. Two aspects 
of the net current records in 4.2 and 3.5 mM [K+]o are noteworthy: (i) The reduction in 
[K+]o and related shift in the underlying, nonlinear, I-V curve for IK1 give rise to a ‘flat’ 
trajectory at about 220-250 ms (within the plateau). This is important since it will render 
this phase of the AP very sensitive to intrinsic (e.g. autonomic transmitter) or extrinsic 
(stretch and/or applied current) perturbations. (ii) The entire net current I-V relation, i.e. 
the repolarization reserve capacity, shows anomalous dependence on [K+]o: reducing 
[K+]o decreases the repolarization reserve in spite of the net current being K
+ selective 
and the electrochemical driving force for  K+ being increased. 
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Another demonstration of the practical significance of alterations in plasma [K+]o 
within its physiological range can be illustrated with an analysis of some aspects of the 
frequency-dependence of AP waveform.48,49. In both experimental and clinical settings, 
this cardiac electrophysiological information can be obtained using two distinct, but 
related protocols. The first protocol involves measuring AP duration at a fixed level of 
repolarization (in our case APD60), while introducing a single extra-stimulus in the 
diastolic period following a stimulation train (S1) at 1 Hz.  The resulting data, denoted 
the interval-duration relation, or restitution curve for repolarization, when obtained at 1 
Hz steady-state simulation in either 5.4 or 3.5 mM [K+]o, is shown in Fig. 2A.  In this 
Figure each data point corresponds to the APD60 at a selected inter-stimulus, or S1-S2, 
value.  In both Figs. 2A and 2B the data set denoted by black circles was obtained using 
a [K+]o of 5.4 mM, while the data denoted by red triangles was obtained in 3.5 mM [K
+]o. 
Note that (as expected from Fig. 1) the lengthening in the AP due to reducing [K+]o from 
5.4 to 3.5 mM results in an upward shift of these I-D relations or restitution curves. This 
upward shift is regulated by the increased duration of the AP, and the corresponding 
lengthening of the relative refractory period. The data in Fig. 2B consists of analogous 
results obtained at a steady-state stimulus frequency of 2.5 Hz.  In this case, the 
lengthening of the AP in 3.5 mM [K+]o also results in 2 distinct I-D curve trajectories
48-50  
 
[Fig. 2 near here] 
 
As mentioned, repolarization reserve is a useful concept for assessing the 
stability of an electrophysiological substrate.  It is also well recognized that the 
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impedance profile (relative changes in input resistance as a function of the phase of the 
AP waveform; i.e. plateau, early repolarization, late repolarization and/or in diastole) can 
strongly modulate not only repolarization but also intercellular communication.  Both of 
these factors contribute to the essential properties of the ventricular syncytium. The 
classical work of Weidmann first demonstrated that during the plateau of the cardiac 
(Purkinje fiber) AP, the input resistance was 2.5 - 4.0 times larger than that measured 
during diastole.47 
Since changes in [K+]o alter both the resting potential and the AP waveform in the 
ventricle,13,14,18 we have used an approach developed by Zaniboni et al.51,52 to calculate 
relative input resistance at three different phases of the simulated electrophysiological 
activity in human ventricle in the presence of selected [K+]o conditions. These 
calculations were done and are illustrated in Fig. 3: (i) during diastole, (ii) at the AP 
plateau and (iii) during final (late) repolarization.  As expected (and summarized in 
Table 1), alterations in [K+]o resulted in significant and progressive changes in this 
profile of phase-specific slope resistances.  
With respect to the main focus of this review, note that decreasing [K+]o from 
normal (5.4 or 4.2 mM) to 3.5 mM caused an approximately 10-25% increase in input 
resistance during diastole. During the plateau (at 0 mV) the input resistance in low [K+]o 
increases 5-10 fold; and in final repolarization (-40 mV) the myocyte also exhibited 
enhanced (30-50%) input resistance. These changes would be expected to reduce the 
electrophysiological stability of the human ventricular myocyte during diastole.  They 
would also make the preparation (myocyte or trabeculum) more sensitive to external 
stimuli during the plateau.  Note also that these changes can be detected during 
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approximately 25-30% of the electrophysiological duty cycle that corresponds to each 
heartbeat. 
 
[Fig. 3 and Table 1 near here] 
 
It has previously been demonstrated that superfusion with reduced [K+]o and/or 
reductions in IK1 (or HERG) may result in an increased incidence of early after-
depolarizations (EADs) in mammalian ventricle.53-56  Accordingly, we have explored: i) 
changes in HERG and/or IK1 that can result in EAD generation and also ii)  determined 
whether co-incident reductions in [K+]o could be considered to be an additional pro-
arrhythmic factor or ‘double hit’. Our choice of the ORd model34 as a platform for this 
illustrated review and the decision to modify it (as explained in conjunction with Figs. S1 
and S2) was based in part on the previously demonstrated capability of this model to 
mathematically simulate EADs in both single isolated human ventricular myocytes; and 
also in multi-cellular strands (trabeculae) or ventricular transmural wedge preparations. 
The three superimposed traces in Fig. 4 an interesting and informative pattern of 
in silico responses. In all cases, the experimental conditions of Guo et al.53 are 
replicated, so that a defined substrate for EAD generation could be used as a starting 
point.  Specifically, this human ventricular myocyte was driven at a low rate (0.25 Hz) in 
normal [K+]o (5.4 or 4.2 mM) and HERG was reduced significantly (by 70%). As 
expected, the AP lengthened substantially, and in 4.2 mM [K+]o there was a 
hyperpolarization of the resting potential.  A second set of simulations were done under 
these same conditions except that [K+]o was reduced from 4.2 to 3.5 mM. The results 
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revealed not only hyperpolarization of the resting potential but also EAD formation near 
the end of the AP plateau. 
 
Note, (as shown in Fig. 3) that reduction in [K+]o would be expected to 
alter/enhance intercellular coupling due to the [K+]o-sensitive change in impedance 
profile at depolarized membrane potentials. In principle, this could result in the coupled 
myocytes exhibiting an enhanced pro-arrhythmic profile due to increased EAD activity 
that could propagate to neighboring myocytes. It is also likely that the changes in cell-to-
cell transcellular electrotonic currents could contribute to de novo EAD generation in 
‘downstream’ myocytes in the ventricular myocardium.  
 
[Fig. 4 near here] 
 
Important principles and functional aspects of the effects of low [K+]o on the 
transmural conduction and electrophysiological stability/responsiveness of the human 
ventricular action potential are illustrated in the Supplementary Section (Fig. S-3). 
These simulations and the resulting mechanistic insights concerning ventricular 
substrate excitability and stability are similar to those revealed previously by 
mathematical simulations of the guinea pig ventricle myocyte action potential.20Both of 
these sets of simulations suggest that particularly in settings of low heart rate, the 
abnormally long diastolic intervals contribute to pro-arrhythmic electrophysiological 
‘triggers’ can emerge partially in response to direct and secondary consequences of low 
[K+]o conditions.  
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New Insights and Perspectives 
This illustrated review demonstrates that key components and principles of 
human ventricular electrophysiology are sensitive to even very small changes in plasma 
[K+]o levels and provides new insights into the underlying ionic targets and mechanisms. 
Some aspects of the effects of low [K+]o on human ventricle have previously been 
studied in detail.,11,20,21,44,57,58 However, in one such paper, [K+]o was reduced very 
substantially, to less than 1mM.57  Under these conditions one would expect the marked 
changes in K+ channel function to also be accompanied by strong inhibition of the 
Na+/K+ pump. 41-43  In contrast, the much smaller range of [K+]o changes selected as a 
basis for this review  often occur as a consequence of normal healthy living activities 
e.g., exercise paradigms.2,3 These conditions may also result from necessary medical 
treatments, such as diuretic therapy.6,7  Recent direct measurements of plasma [K+]o 
activity yield a mean value of approximately 4.2 mM in a healthy adult.11,58 
One consequence of the marked increase in duration of the AP resulting from 
reduced [K+]o is secondary and significantly altered [Ca
2+]i homeostasis.59,60 It is well 
known that the peak of the [Ca2+]i transient elicited by the AP at a fixed heart rate 
increases somewhat, and its duration also lengthens, when [K+]o is decreased. Both of 
these changes would be expected to result in a positive inotropic effect, and indeed this 
has been reported in both guinea pig and rabbit heart preparations.8,61,62 
 
Cellular Mechanisms Regulating Low [K+]o Effects  
Our semi-quantitative analyses of the action potential ‘phase specific’ input 
resistance of the human ventricular AP 51,63,64 that occurs in the setting of low [K+]o also 
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revealed significant changes, (as shown in Fig. 3). These changes would be expected 
to alter the repolarization reserve 38,  and also to indirectly but significantly modulate 
intercellular coupling. 18,47 As we have illustrated, a decrease in [K+]o from approximately 
4.2 – 3.5 mM caused an approx. 3-fold increase in the membrane resistance at the 
resting potential.  Perhaps more importantly, (and as a consequence of the cross-over 
of the ion-transfer or I-V relationships, see Fig S-2), in response to [K+]o changing the 
resistance at the plateau level of the AP can increase very significantly, (approximately 
8-10 fold) . Both of these changes result in the myocyte (and indeed a system of 
connexin-coupled myocytes) being much more sensitive to external perturbations e.g., 
stimulus currents, autonomic or ligand-gated ion channel activation, stretch.  This 
increase in myocyte-to-myocyte coupling may also increase conduction velocity and 
improve contraction synchronicity.  Moreover, it would be expected to also provide an 
increased tendency/capability for abnormal impulses (e.g. EADs or DADs) to alter 
‘distant’ AP waveforms.  Thus, low [K+]o may contribute to a pro-arrhythmic 
substrate.20,44,45 The simulations in Figs. 4 and Fig. S-3 illustrate how that this can 
occur, even in healthy human ventricle. 
Our findings highlight the importance of Kir 2.1 or perhaps 2.2 channels that 
generate an inwardly rectifying, time-independent or background current in ventricular 
myocytes.  It is important, therefore, to recall that a substantial fraction of the cellular 
expression of this type of K+ channel is localized in the T-tubule system.65,66 Recognition 
of this, combined with recent reports demonstrating that in the setting of heart failure 
(HF) the transverse tubular system undergoes significant decrease,66 may explain the 
tendency of the human ventricle in the HF setting to be unstable at, or near, its resting 
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or diastolic range of membrane voltages.  This instability, due to a significant reduction 
in the outward component of IK1, may reveal or unmask pro-arrhythmic tendencies of 
natural products or prescribed drugs that are otherwise considered both safe and 
efficacious even when administered to patient populations with apparently unrelated 
chronic diseases in addition to the setting of heart failure.60,67 
 
Effects of [K+]o on the Relative Refractory Period and Restitution of AP Duration 
It is well known that changes in [K+]o can alter electrophysiological restitution in 
mammalian ventricles.13,20 Perhaps the most straight forward aspect of this is that 
changes in excitability and relative refractoriness are due to the [K+]o-dependent 
alterations in resting potential. The predominant effects of low [K+]o, a significant 
hyperpolarization would be expected to reduce Na+ channel inactivation, and thus 
augment excitability and the associated supernormal period. This effect is well-
established, as judged either in terms of action potential threshold or conduction 
velocity.20,67,68 Restitution of AP duration is also modulated by [K+]o levels. The prevalent 
(classical) explanation for this is that [K+]o-dependent changes in the relevant K
+ 
currents: IK1, IKs, and IKr (HERG) alter (i) resting potential and/or (ii) AP duration at a 
fixed stimulus or heart-rate. The size of IK1 and the deactivation kinetics of HERG and 
IKs modulate the initial slope and the overall trajectory of this interval-duration or 





Translational Significance of Low [K+]o Effects 
Structure-function aspects of projects in Medicinal Chemistry and the Safety 
Pharmaceutical Groups in industry and in governments may need to consider and 
integrate the marked, often nonlinear effects that even small changes in plasma [K+]o 
levels can have on the standard and well-accepted ‘lumped parameters’ that are used 
as standard criteria/end points.69,70 For example, ‘efficacy’ as judged by concentration-
response relationships; and safety profiles for pro-arrhythmic tendencies (as monitored 
by APD measurements on rate-corrected Q-T data) may not be able to be attributed 
entirely and mainly to changes in HERG. These parameters may change significantly as 
a consequence of activity, drug (diuretic therapy) or diet-induced alterations in plasma 
electrolytes. It is beginning to be recognized that developing more robust criteria for 
Drug Safety will need to include a battery of coincident effects of drug candidates on 
plausible ion channel targets.71-74 This constructive change in approach and perhaps in 
policy needs to include detailed consideration of plasma [K+]o levels. 
Perhaps the most obvious application of our findings to Clinical 
Pharmacology/Therapeutics would be patient groups that are receiving diuretic therapy 
in conjunction with drugs administered with the goal of achieving improved rate or 
rhythm control. While it is acknowledged that this group will be heterogeneous, it may 
be that consideration of possible contributions of plasma [K+]o to (i) pro-arrhythmic 
incidence, or (ii) related e.g. muscle twitches or camping worthwhile as one criterion of 
drug efficacy and related tolerance/compliance.  
It is well-known from clinical studies of the relationship between [K+]o and 
mortality that either low or high [K+]o can increase mortality rates.
75-76 The principles and 
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illustrations in this review provide insights into that finding: both high and low K+ 
depolarize human ventricular tissue (and Purkinje fibres) while also markedly changing 
the action potential waveform and substrate impedance (input resistance ‘along’ the 
action potential plateau).  
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Figure 1. Illustration of the responses of the delayed rectifier K+ currents (HERG and 
IKs) and Na
+/K+ pump current in human ventricle to the changes in [K+]o chosen for this 
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study. Panel A shows four superimposed action potentials (APs) at steady state (1 Hz) 
in response to changes in [K+]o. These simulations were done using our modified ORd 
model of the human ventricular myocyte AP. That is, the mathematical expressions for 
IK1 from the GBP model were substituted for those in the published ORd and the 
changes described in the Methods section were introduced. Note the marked changes 
in resting potential, together with altered AP durations at all membrane potentials 
negative to 0 mV. Panel B  shows the alterations in IK1 produced by these changes in 
[K+]o. The data in Panel C illustrate the analogous responses of HERG to changes 
in[K+]o. As expected from experimental findings and clinical data sets the decrease [K
+]o 
from the normal range, either 5.4 mM (experimental) or 4.2 mM (human plasma K+ 
levels) reduce the current and lengthen the AP, in spite of the fact that the 
electrochemical driving force for K+ is increased by this maneuver, namely decreasing 
[K+]o to 3.5 mM. Note (Panel D) that the response of IKs to a decrease in [K+]o is 
conventional: that is, as the driving force is increased by the simulated decrease in 
[K+]o, peak current increases. Panel E in this Figure shows the electrogenic current 
generated by the Na+/K+ pump. In both the ORd and GPB models, this current exhibits 
intrinsic voltage-dependence, as indicated by the fact that it ‘scales’ as the alterations in 
[K+]o change the resting potential and/or the height or duration of the AP. For these 
reasons, this current increases in low [K+]o. Note, that both IKs and IP are much smaller 
(approximately 10x) than either IK1 or HERG. See Results and Discussion for further 
explanation. Panel F shows the corresponding net currents (calculated using the 
method developed by Zaniboni.63,64 Note that reducing [K+]o decreases the net current 
corresponding to both the early and late repolarization phases of the AP. Thus, 




Figure 2. Illustration of the effects of reductions in [K+]o on the action potential (AP) 
durations at 1 Hz (Panel A) and 2.5 Hz (Panel B). These results are presented as 
restitution curves, i.e. the APD in response to a single extra-stimulus (S2) measured at 
APD60, the 60% repolarization level of the AP. For these simulations, our modified ORd 
model was used. Both the patterns of results are conventional: AP duration shortens as 
the diastolic interval deceases. The increase in AP duration in response to the decrease 
to 3.5 mM in [K+]o results in the restitution curve shifting in the upward direction by an 







Figure 3. Calculation of the changes in input (slope) resistance within defined ranges of 
membrane potential in control (5.4 mM, experimental; or 4.2 mM clinical) [K+]o 
conditions, and also in high (8mM) and low (3.5 mM) [K+]o during the action potential 
(AP) in a human ventricular myocyte. The arrows in Panel A illustrate the data collection 
points for each of the 4 superimposed AP (1 Hz, steady-state) waveforms. Panels B-E 
show the slope resistance in the defined ranges of membrane potential. The 
corresponding numerical data are summarized in Table 1. Note that in low [K+]o (3.5 
mM), there is a significant increase in input resistance (i) at resting potential; and (ii) at 
membrane potentials corresponding to the AP plateau. Action potentials (APs) were 
computed using the modified O’Hara et al. model (ORd_m) assuming [K+]o (8, 5.4, 4.2, 
and 3.5 mM), respectively. The arrows indicate the membrane voltage levels (Vm) for 
which I-V curves were constructed. Panels B, C, D, and E. Total membrane I-V curves 
for [K+]o of 8, 5.4, 4.2, and 3.5 mM, respectively, computed as in Zaniboni 2011 and 




Figure 4. In low [K+]o, early after-depolarizations (EADs) may develop at the plateau 
level of the action potential (AP) in human ventricular myocyte. Three simulations were 
performed using our modified O’Hara et al. model (ORd_m), assuming 5.4, 4.2, or 3.5 
mM [K+]o. The stimulus basic cycle length (BCL) was 4000 ms, or 0.25 Hz. Note that 
EADs were generated only when [K+]o was 3.5 mM. The membrane potential (Vm) from 
which EADs develop is indicated by the discontinuous horizontal line. (See text for 




Membrane Resistance Changes as a Function of [K+]o and Phase of the 
Action Potential  
Vm(mV) [K]o = 8 mM 
Rm M 
[K]o = 5.4 mM 
Rm M 
[K]o = 4.2 mM 
Rm M 
[K]o = 3.5mM 
Rm M 
40 90 44 43 40 
20 333 290 282 284 
0 -1465 -2922 -10852 22626 
-20 -269 -711 -2132 -3554 
-40 -198 -269 -361 -495 
V(rest) 24 29 34 37 
 
Table 1. Membrane resistance (Rm, Megaohms) calculated as the inverse of the slope 
of the instantaneous I-V curves shown in Figure 7 (panels B, C, D, and E). Rm was 






Mathematical models of the human ventricular action potential  
To succinctly convey the main principles that are the basis of this Review, 
mathematical simulations of the electrical activity of endocardial human ventricular 
myocytes were done using the two most comprehensive published action potential (AP) 
models: Grandi et al. (GPB),1 and O’Hara et al. (ORd).2 The GPB model is based on 
detailed semi-quantitative descriptions of intracellular calcium homeostasis, as well as 
the main ionic currents, derived from a subset of published human ventricle data. It has 
proven to be a useful tool for simulating the normal AP and related repolarization 
abnormalities.  
The ORd model2 originates from the extensive rigorous work of the Rudy Group 
on guinea pig ventricular myocytes3 . Importantly, however, it is based on experimental 
data taken from 140 healthy human hearts. This model includes detailed mathematical 
formulations for 18 ionic currents and also provides the possibility of computing AP 
waveforms for phenotypic subsets of heart cells: endocardial, epicardial, and M 
myocytes. The inclusion of these transmural electrophysiological heterogeneities in the 
ORd model is an important capability. This model also provides the possibility of 
carrying out 1-dimensional transmural ‘ventricular wedge’ simulations and these can be 
used to explore the basis for changes in pseudo-electrocardiograms (ECGs) as shown 





Computational methods  
The GPB and ORd model differential equations were both implemented in Matlab 
(Math-works Inc., Natick, MA, USA) and then solved numerically using a variable order 
solver (ode15s) as we have done in previous published work.4 All model equations and 
code were taken from O’Hara et al.2 which was downloaded from 
http://rudylab.wustl.edu, and 1D simulations were run using Microsoft Visual C++.   
 
Validation and modification of these action potential models for simulations of 
hypokalemia 
As a first step in developing illustrative material for this Review the effects of 
changes in [K+]o on the human ventricular AP were compared using GPB and ORd  
models.  Figure S-1 shows the marked prolongation (or shortening) of the AP under 
simulated hypokalemic ([K+]o=3.5 mM)
5,6 and hyperkalemic ([K+]o=8 mM) conditions, 
respectively.  For both models, the baseline or control [K+]o was set at 5.4 mM:  the 
value is most common in experimental studies.  
Somewhat to our surprise, the simulated action potentials and changes in resting 
potential produced by these two models of the human ventricular myocyte differed very 
significantly when [K+]o was altered.  Specifically, there was an increase of the inward-
rectifying K+ current (IK1) when [K
+]o was decreased to 2.5 mM using the ORd model 
(Figure S-1D).   In contrast, IK1 current density decreased quite markedly in the GPB 
model (Figure S-1C) in response to this maneuver. Since it is well known that IK1 




[Figure S1 near here] 
 
Figure S-2A shows simulated I-V curves for IK1 using the published ORd model
2.  
This was done in an attempt to reproduce the relevant patterns of published 
experimental results such as those from our previous paper9 that are illustrated in the 
inset of this Figure.  Unfortunately, an incorrect increase in IK1 in low [K
+]o was observed. 
In contrast, and as noted, when the GPB1 formulation of IK1 was used to simulate low 
[K+]o (Fig. S-2B), this model quite accurately reproduced the experimental observations.  
We therefore gave serious consideration to utilizing only the GPB model for the 
illustrations in this review.  However, the ORd model is based on an impressive cross-
section of experimental data from human ventricle; and it provides the possibility of 
examining the effects of changes in [K+]o on transmural AP propagation and the pseudo 
ECG.  In addition, the ORd model has been selected for the Systems Biology 
component of this ongoing CiPA initiative that is expected to result in changed Safety 
Pharmacology Guidelines for anti-arrhythmic drug assessments.12 
 We therefore modified the published ORd model2 so that it could accurately 
replicate the well-known responses to altering [K+]o.  This was done by introducing the 
IK1 formulation from GPB into the ORd AP model, i.e., replacing the original ORd IK1 
equations.  We also noted that the resting potential (Vrest) in control conditions in the 
ORd model is much more hyperpolarized (Vrest = -88 mV) than in the GPB model (Vrest = 
-81 mV).  As a consequence, in the ORd model Vrest and Ek are identical, thus the IK1 
value at rest was zero.  Accordingly, for all our simulations Vrest was adjusted to -86.5 
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mV in the ORd model.  This was achieved by: (i) decreasing the Na+/K+ pump current 
(INaK) density by 30%, (ii) introducing the GPB formulation for the background Na
+ 
current (INab).  This results in a 3-fold increase in this current density and (iii) decreasing 
the background K+ current (IKb) by 50%. The resulting behavior of the modified ORd 
model (denoted ORd_m) for selected [K+]o levels is shown in Figure S-1.  
 
[Figure S-2 near here] 
 
In silico stimulation and analysis protocols  
Ventricular myocytes were stimulated in silico at 1Hz (unless otherwise specified) 
until steady-state conditions were achieved.  To model the restitution curves for AP 
duration (APD) shown in text or main body of this paper as Fig. 2, each APD was 
measured at 60% repolarization (APD60).  Specifically, ventricular myocytes were 
subjected to a 1 Hz or 2.5 Hz stimulus train, until steady-state conditions were achieved.  
A single extra-stimulus was then applied at each selected coupling interval, ranging 
from approximately 1000 ms to 230 ms.  These intervals varied somewhat depending 
upon the chosen steady-state stimulation frequency (either 1 Hz or 2.5 Hz).  In practice, 
the AP lengthening caused by simulated effects of low [K+]o meant that in 3.5 mM [K
+]o 
the smallest inter-stimulus interval was 260 ms.  The APD60 values corresponding to the 
selected S2 stimuli were plotted vs. the diastolic interval as shown in Figure S-2A, B13-15 




Membrane resistance computations  
The membrane resistance (Rm) was calculated using the approach developed by 
Zaniboni16,17.  In brief, the total membrane current (Im) was sampled and divided by the 
membrane voltage (Vm), at the selected points within the small voltage range (Vmx) 
indicated by arrows in text Figure 3A.  Myocytes were stimulated at 1 Hz.   After 
achieving steady-state conditions, each simulation was interrupted at a chosen time 
during the AP plateau or repolarization.  These times are denoted Vx in Figure 3A.  At 
each the total ionic current (Iionx) was measured and the capacitive current (IC) was 
calculated.  Vm was then immediately maintained constant or voltage clamped for 10 
msec at the selected values denoted:  Vx, Vx–10 mV, or Vx+10 mV.  In Figure S-3, the 
sympol x denotes the time at which the resistance was calculated.  Im was computed as 
the total ionic current measured at 1 ms after the onset of the voltage clamp (Iion).  From 
this data Im-Vm curves were constructed and Rm was calculated as the reciprocal of the 
slope of these curves. 
 
Simulations of 1-dimensional conduction using the ORd transmural wedge model  
In these simulations (illustrated in Fig. S-3A and B), our modified ORd model of 
the human ventricular AP was utilized together with a heterogeneous substrate 
consisting of a 1-dimensional strand of 165 myocytes that were coupled end-to-end. A 
train of 700 suprathreshold stimuli was applied at 1 Hz the extreme endocardial of this 
strand or in silico wedge preparation. After steady-state was achieved, measurements 
of AP waveform were recorded as in O’Hara et al.2   The resulting AP propagated in the 
‘inside-out’ direction, thus replicating some aspects of transmural activation and 
 42 
conduction in the human left ventricle. To enhance the probability of EAD generation, a 
number of changes in the baseline parameter set of the ORd model were introduced.  
Each of these was selected to align with published information concerning arrhythmia 
(EAD) induction in human ventricles.18-22 The control (5.4 mM) electrophysiological 
waveforms in either 5.4 mM or 3.5 mM [K+]o at a steady rate of 0.25 Hz, are shown in 
Panels A and B, respectively. In each panel the selected colors illustrate the AP 
waveforms at fixed positions denoted by cell number: (i) blue, cell #32, endocardium; (ii) 
red, cell #65, M cell region; (iii) green, cell #98, M cell region; and (iv) magenta, cell 
#132, epicardium. This somewhat simplified initial analysis, shows that in low [K+]o the 
EAD complex can move from myocyte to myocyte more readily23-27 mainly due to the 
altered ratio of myocyte input resistance to intercellular/atrial resistance arising from the 
K+ induced nonlinear changes in IK1. 
 
 [Fig. S-3 near here] 
 
Limitations and opportunities for additional studies 
This review provides current information concerning the marked sensitivity of 
human ventricular electrophysiology to [K+]o, with emphasis on the effects of low but 
clinically relevant [K+]o levels, approx. 4 mM.
28,29  Our illustrations are based upon a 
modified (corrected) computational platform for some Systems Biology components of 
multidisciplinary studies of human ventricle electrophysiology and pharmacology/drug 
discovery. We acknowledge, however, that our work has some significant limitations.  
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1. We have focused on the electrophysiological effects of changes in physiological 
levels of [K+]o in isolated human ventricular myocytes. However, our insights may 
apply mainly to the endocardium of the left ventricle, since only this ‘module’ of 
the published O’Hara model2 was used.  Major changes were observed in the 
resting potential and late repolarization, both in the parent model and after 
necessary corrections were introduced.  Although the underlying ionic 
mechanisms for these two phases for the duty cycle of cardiac 
electrophysiological activity30 are somewhat different in the epicardium and in in 
the endocardium, many of our illustrations and related insights are expected to 
apply to the healthy ventricular myocardium per se30. We recognize, however, 
that the wave-shape of the AP, and indeed the basis for the transmural 
electrophysiological heterogeneity, results from small changes in net currents 
within selective voltage ranges of the action potential.27, 31-33 Thus, additional 
work may need to be done, in which the epicardium and endocardium APs are 
compared.  
2. It was necessary to formulate a substantially revised hybrid model of the human 
ventricular AP. Our initial analysis revealed that the ORd model has only very 
limited ability to maintain excitability (initiated action potential) in any setting 
involving resting membrane potential depolarization. Perhaps more importantly, 
the mathematical formulation for the inwardly rectifying background K+ current in 
the ORd model cannot reconstruct or simulate the fundamental and well-known 
response of the IK1 current system, to either increases or decreases in [K
+]o. In 
principle, there was the possibility of using the GPB model for all of the 
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calculations in this paper. However, we have encountered significant practical 
difficulties in introducing the GPB model into the linear cable or transmural 
wedge preparation, and therefore made use only of the modified ORd model.  
3. This study draws attention to, but does not treat in any comprehensive way, how 
changes in [K+]o can modulate intercellular coupling. We demonstrate that even 
small changes in [K+]o can alter the input resistance of the myocytes subjected to 
low [K+]o, and we confirm that in cases where the input resistance at the plateau 
level of the AP increases significantly (See Table 1) these myocytes become 
more effective current sources provided that intercellular resistance remains 
constant. This small change is functionally important in a number of plausible 
pathophysiological settings: it results in a change in ‘substrate’ that enhances the 
likelihood of EAD generation and cell-to-cell movement/propagation.34,35 
4. It will be apparent that the scope of this project was such that a number of 
important features of the heterogeneity of the human ventricular myocardium are 
not fully (or even adequately) accounted for.  Thus, we have assumed that the 
selected changes in [K+]o would be homogenous throughout the ventricular 
myocardium. This is somewhat unlikely. Our interpretation assumes that the K+ 
channels that sense alterations in [K+]o are expressed exclusively in ventricular 
myocytes. This is known to be incorrect. Kiv 2.1/2.2 channels are expressed in 
endothelial cells, vascular pericytes, and smooth muscle myocytes from 
‘resistance’ vessels/arterioles,36 changes in [K+]o would therefore alter transmural 
ventricular perfusion profiles. IK1 currents are also expressed in ventricular 
fibroblasts and myofibroblasts.37-39 Modulation of this current in these non-
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myocytes as a consequence of changes in [K+]o would be expected to alter 
ventricular myocyte AP and/or resting potential waveform, due to connexin-
mediated electrotonic current flow.27 
5. Our computations and analyses concerning the interval-duration relationships or 
restitution curves for APD60 (Fig. 2) provide insight into the underlying changes in 
K+ currents that are major contributors. We recognize, however, that re-activation 
of ICa-L is also an important contributor.
27 We are also aware that in human hearts 
electrophysiological restitution (whether measured in terms of conduction velocity 
or APD) is measurement site specific and often non-monotonic. The reasons 
involve a contribution from the time-dependent reactivation of a transient-outward 
K+ current. However, this interesting principle 27 was not the focus of our study.  
6. It is well-known that the ventricular myocardium, as opposed to the isolated 
single ventricular myocyte reacts to imposed changes in stimulus or heart rate, or 
alterations in plasma electrolyte content with two distinct time courses.15 The 
faster of these takes place in a time window of approx. 30 sec; in contrast, 
important slower adaptation in action potential waveform and contractility also 
take place and these develop over 1-10 minutes after the rate or electrolyte 
changes. The Eisner Group15 has studied these slower results in detail an 
attributed them to a combination of key ion fluxes (e.g. K+) taking place in an 
environment of restricted diffusion and related changes in Na+/K+ pump activity. 
Perhaps for this reason a number of recent reviews of K+ dependent alterations 
of atrial or ventricular electrophysiological activity have strongly emphasized 
electrogenic pump contribution.40,41  
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7. We recognize also that in clinical settings there are significant and quite wide 
variations in substrate responsiveness to changes in electrolytes and/or changes 
in drug regimens.  In our initial attempt to illustrate the effects of hypokalemia on 
fundamental electrophysiological properties of the human myocardium, individual 
variations and hence Precision Medicine has not been addressed.42-44 
8. Within the last decade the overall capacity of myocardial cells has been 
described in terms of their repolarization reserve.27, 45-47 Although this concept is 
meaningful and often useful it needs to be utilized and applied selectively and 
with caution when critical components of it, that is significant parts of the net 
current that initiates and then drives repolarization consists of nonlinear currents 
such as the two that are the focus of this review, IK-1 and HERG.
48 We have dealt 
with this interesting point in our recent review on the dynamics of early 
repolarization.27 
9. A final significant limitation of the Illustrated Review concerns the extent to which 
the underlying principles have been set out sufficiently with regard to (i) previous 
experimental work, and (ii) very recent translational findings. With regard to the 
former we acknowledge the classical work from the Moe laboratory 48 and related 
publications from the Jalife Group 49,50 that were among the first to bring out the 
significance of electrotonic modulation of pacemaker activity, excitability 
conduction patterns and velocity, and relate these to [K+]o dependent changes in 
the background K+ current, IK1. Very recent publications that relate to the main 
principles of this review include: (a) the recognition that both hypo- and 
hyperkalemia need to be accounted for in the treatment management of 
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hypertension nad diastolic dysfunction 51,52; (b) emerging data sets that advance 
our understanding of the molecular basis for the interactions of [K+]o with defining 
ion channel or ion channel complex components, and (c) the indication that 
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Figures and Legends 
 
Figure S-1 Response of the inwardly rectifying K+ current, IK1, in a human ventricular 
myocyte to selected changes in [K+]o. Panels A and B show the changes in resting 
potential and in action potential (AP) waveform in response to the four [K+]o values listed 
in the upper right-hand corner. The 4 superimposed APs in Panel A were computed 
using the Grandi et al. (GPB) model, while the four on the right are from the O’Hara et 
al. (ORd) model of human (endocardial) ventricular myocyte. The corresponding data 
sets in Panels C and D show the underlying changes in IK1 during the AP in response to 
these selected alterations in [K+]o. Note, that the GPB model correctly simulates the 
anomalous decrease in peak IK1 when [K
+]o is decreased, while in the ORd model an 
incorrect pattern of results is obtained: namely, IK1 increases when [K
+]o is decreased. In 
this and all subsequent figures, the two [K+]o that approximate the normal range for 
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experimental work (5.4 mM) and the mean value for plasma K+ activity (4.2 mM) are 
denoted by the thick black and dashed black traces, respectively. Physiological 
increases in [K+]o to 8 mM are indicated by the red traces, while low levels of [K
+]o (3.5 
mM) are illustrated by the thin black traces.  
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Figure S-2. Illustrations of the marked changes in size and voltage-dependence of the 
nonlinear I-V curve for IK1 computed using the original O’Hara et al. model (ORd) (panel 
A) versus the Grandi et al. model (GPB) (panel B), for [K+]o of 2, 5.4 and 10 mM. The 
inset shows experimental data published by Shimoni et al.16 obtained at different [K+]o 
levels. Note that the original ORd model for IK1 does not reproduce this well-established 
pattern of changes in IK1, in response to these changes in [K
+]o whereas GPB 






Figure S-3. Evaluation of the effects of low [K+]o on EAD propagation based on 
computations done using our modified ORd model of the human ventricular action 
potential (AP). The chosen in silico ventricular myocyte ‘substrate’ corresponds to a 
transmural 1-D strand or cable: 165 myocytes were arranged end-to-end in a strand. A 
suprathreshold stimulus applied to the extreme endocardial end of this strand elicited an 
AP that propagated through the endocardial, M, and epicardial myocytes. The patterns 
of responses in [K+]o 5.4 and 3.5 mM are represented in Panels A and B, respectively. 
To enhance the likelihood that early after-depolarizations (EADs), a 70% block of the 
rapid delayed rectifier current (IKr) and a 20% enhancement of the late sodium current 
(INaL) were introduced. The stimulus basic cycle length (BCL) was 4000 ms and 
intracellular conductivity was set to achieve a conduction velocity of 41 cm/s.93,94 The 
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colors of the APs correspond to the selected regions (cell number) within the strand: cell 
32 – endo (blue); cell 65 – M (red); cell 98 – M (green); cell 132 – epi (magenta). See 
text for further explanation. ‘M’ denotes mid-myocardium.  
 
 
 
